David Baker

Pharmaco-metabonomic phenotyping and personalized drug treatment

T. Andrew Clayton, John C. Lindon, Olivier Cloarec et al. · Nature · 2006 · 827 citations

Medicine, Molecular Medicine, Pharmacology +14

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

T. Andrew Clayton, David Baker, John C. Lindon et al. · Proceedings of the National Academy of Sciences · 2009 · 764 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Cannabinoids control spasticity and tremor in a multiple sclerosis model

David Baker, Gareth Pryce, J. Ludovic Croxford et al. · Nature · 2000 · 531 citations

Medicine, Neurology, Neuroscience +14

Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain

Luigia Cristino, Luciano De Petrocellis, Gareth Pryce et al. · Neuroscience · 2006 · 488 citations

Life Sciences, Neurobiology, Neuroscience +13

Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.

Sandra Amor, N. P. Groome, Christopher Linington et al. · The Journal of Immunology · 1994 · 379 citations

Life Sciences, Immunology, Neurology +15